Search Results
10
Everything
Search Filters
Tag
Neurology
Kevin Kearney Joins Lungpacer Medical as Chief Commercial Officer
March 24, 2025 07:00 ET
|
Lungpacer Medical USA Inc.
Lungpacer Medical Appoints Medical Device and Healthcare Industry Veteran with 20 Years of Experience as CCO
ZHITTYA GENESIS MEDICINE ANNOUNCES: DR. JACK JACOBS, PRESIDENT, TO RECEIVE NEVADABIO HONOR FOR PARKINSON’S DISEASE BREAKTHROUGH
March 18, 2025 10:00 ET
|
Zhittya Genesis Medicine Inc
Parkinson's disease reversed for 200 human medical research patients
Rare Neurological Disease Treatment Market to Reach USD 115.8 Billion by 2035, Growing at 9.7% CAGR | Fact.MR Report
March 18, 2025 07:30 ET
|
FACT.MR
Rockville, MD, March 18, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the The global rare neurological disease treatment market was valued...
Montara Therapeutics Closes $20M Oversubscribed Seed Expansion, Appoints Troy Wilson as Chairman of the Board
March 13, 2025 08:00 ET
|
Montara Therapeutics
Montara Therapeutics closed a $20 million oversubscribed expansion of its Series Seed financing. Troy Wilson joins as Chairman of the Board.
BD² ANNOUNCES FOUR NEW SITES TO JOIN LANDMARK BIPOLAR DISORDER RESEARCH AND CLINICAL CARE NETWORK
March 12, 2025 08:00 ET
|
BD²: Breakthrough Discoveries for Thriving with Bipolar Disorder
Washington, D.C, March 12, 2025 (GLOBE NEWSWIRE) -- Today, Breakthrough Discoveries for thriving with Bipolar Disorder (BD²) announced four new national institutions to receive $2.3 million each to...
AB Science : Un article de la revue de référence Life Sciences Magazine présente le masitinib et son investigateur principal de Phase 3, le neurologue Patrick Vermersch
March 04, 2025 02:35 ET
|
AB Science
COMMUNIQUE DE PRESSE UN ARTICLE DE LA REVUE DE REFERENCE LIFE SCIENCES MAGAZINE PRÉSENTE LE MASITINIB D'AB SCIENCE ET SON INVESTIGATEUR PRINCIPAL DE PHASE 3, LE NEUROLOGUE PATRICK VERMERSCH Paris, 4...
AB Science: Article from the leading publication Life Sciences Magazine featuring masitinib and its Phase 3 principal investigator, the neurologist Patrick Vermersch
March 04, 2025 02:35 ET
|
AB Science
PRESS RELEASE ARTICLE FROM THE LEADING PUBLICATION LIFE SCIENCES MAGAZINE FEATURING AB SCIENCE’S MASITINIB AND ITS PHASE 3 PRINCIPAL INVESTIGATOR, THE NEUROLOGIST PATRICK VERMERSCH Paris, March 04,...
Neurology Market Research Overview 2024-2029: Growing Geriatric Population with Neurological Disorders and Increasing Global Incidence of Neurological Disorders Fueling Developments
March 03, 2025 07:21 ET
|
Research and Markets
Dublin, March 03, 2025 (GLOBE NEWSWIRE) -- The "Neurology Market: Research Overview" report has been added to ResearchAndMarkets.com's offering.The Neurology Market was valued at USD 67.3 Billion...
Zhittya Genesis Medicine Announces: Landmark fMRI Study Reveals 21.2% Boost in Brain Blood Flow in Parkinson’s Patient Following Six Months of Intranasal FGF-1 Therapy
February 27, 2025 11:00 ET
|
Zhittya Genesis Medicine Inc
Groundbreaking fMRI study that showed a 21.2% increase in brain blood flow in a Parkinson’s patient after six months of intranasal FGF1 therapy.
Precision Neuroscience Expands Clinical Research in Brain–Computer Interface Through Collaboration with Beth Israel Deaconess Medical Center
February 27, 2025 09:00 ET
|
Precision Neuroscience
NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation, a pioneering brain–computer interface (BCI) company, today announced a clinical research project with Beth Israel...